What is the Next Stage of Cannabis Investing?
Ryan Allway
January 13th, 2020
App, Exclusive, News, Top News
Remember when investments in cannabis and Bitcoin were seen as interchangeable pursuits of the next sky-high return based on a story that sounded plausible, if not downright enticing? In the early days, cannabis investors chased Canadian operators focused on ramping up production to meet the growing demand of a newly legalized Canadian recreation market and, ultimately, booming markets in the U.S. and overseas. Let’s call that Cannabis Investing 1.0. As the Canadian gold rush faded and more U.S. states legalized marijuana consumption, Cannabis Investing 2.0 shifted focus to U.S.-based multi-state operators (MSOs). The valuation ramp-up for these companies was less meteoric than for their 1.0 counterparts, but the decline was just as certain as U.S. MSO stock prices hit the skids in 2019.
Major retrenchment across the industry may be a sign that the Wild West days are over. Cannabis investors are looking for more stability and clarity in an industry still defined by significant regulatory uncertainty and by young companies with varied capabilities and track records. As this market continues to mature, investors may be looking for a very different Cannabis Investing 3.0.
General Cannabis (OTCQX: CANN) is a Colorado-based holding company building a comprehensive portfolio of business and consumer cannabis brands. Its approach is to acquire best-in-class companies with proven track records of revenue and profitability and provide support including back-office services, marketing assistance and growth capital. This approach is designed to support the entrepreneurs whose vision and passion drive innovation and growth in the industry with solid business and financial practices and resources needed to promote long-term business viability and profitability.
Click here to receive an investor deck and corporate updates
Executing a Stable Growth Strategy
General Cannabis has operating divisions that span real estate, consulting, financing and distribution to grow facilities and dispensaries. This diversity creates what the Hunter Garth, VP of Business Development calls “synergistic opportunities” for operating divisions and subsidiaries to leverage the others’ strengths, take advantage of operational efficiencies, and build a larger balance sheet.
General Cannabis is executing a strategy that focuses on mature markets in Colorado and California, with Oregon on its Phase 2 radar. Garth noted the company’s “operating history and Colorado experience” as attractions to potential acquisition targets in its home state. Watch for General Cannabis to begin closing acquisitions in cultivation, processing and retail from its pipeline in early 2020, with deals Garth said are structured to keep existing management teams in place while the subsidiaries are integrated into the larger General Cannabis family.
A prime example of General Cannabis’ strategy can be seen in its recent announcement of a term sheet to acquire Hälsa Holdings. Upon completion of the deal, General Cannabis will have contracts to acquire 3 retail dispensaries in California that currently generate about $12 million in annual revenue.
As it stands now, Q3 2019 marked the company’s sixth consecutive quarter with revenues surpassing $1 million US, and a 34% increase in year-to-date revenue over 2018.
Click here to receive an investor deck and corporate updates
Seasoned Leadership
In December 2019, Steve Gutterman took the helm as CEO of General Cannabis, bringing with him two decades of experience in the cannabis, market research and banking industries. As the President of Harvest Health & Recreation, Gutterman earned the respect of industry stalwarts by taking one of the largest U.S. MSOs public and overseeing its global operations. Previous executive experience at Mobile Accord and E*TRADE Bank rounds out his qualifications to head up the General Cannabis team with its deep background in cannabis, finance, retail and consumer packaged goods.
Steve Gutterman refers to the company’s place in Cannabis Investing 3.0 as the “second mover” advantage, describing a business strategy that involves acquiring “already-successful, profitable assets in mature markets that require relatively little capital to continue to develop.”
In addition to the company’s Denver headquarters, its 90+ employees are located in Los Angeles, Sacramento and New York, supporting a geographically diversified strategy that retains a focus on mature markets and anticipates opportunity in the populated states of the northeastern United States.
One to Watch?
Part of the General Cannabis formula has been to lay the groundwork for accelerating growth that avoids the overvaluation trap. Its 2019 year-end market cap of $21 million seems modest in the context of an industry that tends toward overblown multiples. A planned capital raise in Q1 2020 will help fund the company’s pipeline of acquisition targets in Colorado and could push projected growth.
As Cannabis Investing 3.0 drives a search for reliability, sound business practices and proven experience to sort out the real opportunities from the “sounds good but no thanks” operators, General Cannabis may be a company for investors to keep an eye on. Watch this space.
Click here to receive an investor deck and corporate updates
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Biome Grow (CSE: BIO) wholly owns Highland Grow, an Authorized Licensed Producer in Nova Scotia under the ACMPR, P-209 Inc., a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the ACMPR.
Revive Therapeutics’ cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
